RhumbLine Advisers’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Buy |
53,450
+3,636
| +7% | +$36.1K | ﹤0.01% | 2653 |
|
|
2025
Q1 | $473K | Buy |
49,814
+3,731
| +8% | +$35.4K | ﹤0.01% | 2613 |
|
|
2024
Q4 | $636K | Buy |
46,083
+14,169
| +44% | +$196K | ﹤0.01% | 2514 |
|
|
2024
Q3 | $485K | Buy |
31,914
+1,028
| +3% | +$15.6K | ﹤0.01% | 2714 |
|
|
2024
Q2 | $147K | Buy |
+30,886
| New | +$147K | ﹤0.01% | 3386 |
|